Effect of Intravenous vitamin c in Patients with COVID-19

Phase 2

Recruiting

• Conditions: covid-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20200411047025N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

At least 18 years old
The case of definite or probable of covid-19

Exclusion Criteria

The patient with chronic renal failure or dialysis
The patient withG6PD deficiency

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of SPO2 (stands for peripheral capillary oxygen saturation). Timepoint: Daily, until 3-5 days or discharge. Method of measurement: pulse oximetry.

Secondary Outcome Measures

Name	Time	Method
Fever subside. Timepoint: 4 times a day until 3-5 days or discharge. Method of measurement: termometer.;CRP. Timepoint: Every other day until discharge. Method of measurement: Laboratory test.;Respiratory rate. Timepoint: 4 times a day until 3-5 days or discharge. Method of measurement: physical examination.;Lymphocytosis. Timepoint: every other day until discharge. Method of measurement: laboratory test.;Creatinine. Timepoint: every other day until discharge. Method of measurement: Laboratory test.